To The Moon
Home
News
TigerAI
Log In
Sign Up
Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)
61.12
-0.82
-1.32%
Market data delayed 15 minutes
Community
Community
News
News
Profile
Profile
Announcements
Announcements
Company Profile
Company Name
江苏恒瑞医药股份有限公司
Industry
医药制造业
Listing Date
2000-10-18
Registered Capital
663719万元
Introduction
江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是硫培非格司亭注射液、马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇胺片、碘佛醇注射液。
No filings yet
1D
5D
Day
Week
Month
Loading ...
High
62.38
Open
61.80
T/O Rate
0.74%
Low
60.66
Close
61.94
Amplitude
2.78%
Most Discussed
{"pagemeta":{"title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.,600276,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎国际,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股价,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股市,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票价格,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票交易,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票购买,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"fillings","symbol":"600276","data":{"stockData":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":61.12,"timestamp":1768806000000,"preClose":61.94,"halted":0,"volume":47389096,"delay":0,"changeRate":-0.0132,"floatShares":6379000000,"shares":6637000000,"eps":1.1252,"marketStatus":"Closed","change":-0.82,"latestTime":"01-19 15:00:00","open":61.8,"high":62.38,"low":60.66,"amount":2910000000,"amplitude":0.0278,"askPrice":61.12,"askSize":8,"bidPrice":61.11,"bidSize":890,"shortable":0,"etf":0,"ttmEps":1.1252,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768872600000},"marketStatusCode":5,"adr":0,"adjPreClose":61.94,"symbolType":"stock","openAndCloseTimeList":[[1768786200000,1768793400000],[1768798800000,1768806000000]],"highLimit":68.13,"lowLimit":55.75,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637199874,"isCdr":false,"pbRate":6.82,"roa":"--","peRate":54.319232,"roe":"11.09%","epsLYR":1,"committee":0.626531,"marketValue":405666000000,"turnoverRate":0.0074,"status":1,"hkstockBrief":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":76.9,"timestamp":1768810085002,"preClose":77.3,"halted":0,"volume":2829870,"delay":0,"premium":"+12.27"},"floatMarketCap":389885000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"listingDate":"2000-10-18","address":"江苏省连云港市连云区经济技术开发区黄河路38号","stockEarnings":[{"period":"1week","weight":-0.0428},{"period":"1month","weight":0.0044},{"period":"3month","weight":-0.0739},{"period":"6month","weight":0.0698},{"period":"1year","weight":0.4319},{"period":"ytd","weight":0.026}],"companyName":"江苏恒瑞医药股份有限公司","boardCode":"AI0027","perCapita":"16058股","boardName":"医药制造业","registeredCapital":"663719万元","compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0575},{"period":"3month","weight":0.0505},{"period":"6month","weight":0.1484},{"period":"1year","weight":0.269},{"period":"ytd","weight":0.0366}],"survey":" 江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是硫培非格司亭注射液、马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇胺片、碘佛醇注射液。","serverTime":1768854931523,"listedPrice":11.98,"stockholders":"397246人(较上一季度增加8.94%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}}}}}
